Advanced search
Publication Cover
Infectious Diseases Volume 54, 2022 - Issue 10
Submit an article Journal homepage
1,345
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Health care costs related to hepatitis B in Finland are mostly due to chronic infections: a register-based study

Tanja Nieminena Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, FinlandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6117-2506
ORCID Icon,
Heini Saloa Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
,
Markku Nurhonenb Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland
&
Tuija Leinoa Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
Pages 722-730 | Received 14 Oct 2021, Accepted 23 May 2022, Published online: 20 Jul 2022

References

  • World Health Organization. Expanded programme on immunization. Global advisory group – part I. Wkly Epidemiol Rec. 1992;67:11–15.
  • Hepatitis B vaccines. WHO position paper. Wkly Epidemiol Rec. 2009;84:405–420.
  • Hepatitis B vaccines. WHO position paper, July 2017. Wkly Epidemiol Rec. 2017;92:369–392.
  • Karvonen T, Auranen K, Kuusi M, et al. Epidemiology of hepatitis B infection in Finland: Implications for immunisation policy. Vaccine. 2017;35(3):412–418.
  • Shepard CW, Simard EP, Finelli L, et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28:112–125.
  • Edmunds WJ, Medley GF, Nokes DJ, et al. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci. 1993;253(1337):197–201.
  • Wright TL, Lau JYN. Clinical aspects of hepatitis B virus infection. Lancet. 1993;342(8883):1340–1344.
  • Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis. 1995;20(4):992–1000.
  • McMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis. 1985;151(4):599–603.
  • Fattovich G, Brollo L, Giustina G, et al. Natural history and prognostic factors for chronic hepatitis type B. Gut. 1991;32(3):294–298.
  • Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48(2):335–352.
  • Venook AP, Papandreou C, Furuse J, et al. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist. 2010;15(Suppl 4):5–13.
  • Alward WL, McMahon BJ, Hall DB, et al. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J Infect Dis. 1985;151(4):604–609.
  • Kennedy M, Alexopoulos SP. Hepatitis B virus infection and liver transplantation. Curr Opin Organ Transplant. 2010;15(3):310–315.
  • Kapiainen S, Väisänen A, Haula T. Terveyden- ja sosiaalihuollon yksikkökustannukset Suomessa vuonna 2011 [The unit costs of health and social care in Finland in 2011]. Helsinki: National Institute for Health and Welfare; 2014.
  • Larønningen S, Ferlay J, Bray F, et al. Version 9.1 (27.09.2021). Association of the Nordic Cancer Registries. Cancer Registry of Norway. [cited 2022 March 14]. Available from: https://nordcan.iarc.fr/.
  • Engholm G, Ferlay J, Christensen N, et al. NORDCAN - a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49(5):725–736.
  • Jiang Y, Li Z, Ji X, et al. Global pattern and trend of liver cancer survival: a systematic review of population-based studies. Hepatoma Res. 2020;6:52.
  • Demir T, Lee S, Kaseb A. Systemic therapy of liver cancer. Adv Cancer Res. 2021;149:257–294.
  • Lee TA, Veenstra DL, Iloeje UH, et al. Cost of chronic hepatitis B infection in the United States. J Clin Gastroenterol. 2004;38(10 Suppl 3):S144–S7.
  • Butler JR, Pianko S, Korda RJ, et al. The direct cost of managing patients with chronic hepatitis B infection in Australia. J Clin Gastroenterol. 2004;38(10 Suppl 3):S187–S92.
  • Harbarth S, Szucs T, Berger K, et al. The economic burden of hepatitis B in Germany. Eur J Epidemiol. 2000;16(2):173–177.
  • European Association for the Study of the Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012;57:167–185.
  • European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370–398.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.